FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to biochemistry, particularly to using a peptide produced of human lactoferrin as a masking agent. What is also disclosed is a method for producing a pharmaceutical composition.
EFFECT: invention possesses an ability to mask a biologically active substance and prevent an unwanted IgG or IgE immune response.
8 cl, 6 dwg, 4 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2582916C2 |
METHOD OF SEPARATING LACTOFERRIN OF HUMAN AND GOAT BY MEANS OF DIFFERENTIAL IMMUNOAFFINITY CHROMATOGRAPHY USING SINGLE-DOMAIN MINI-ANTIBODIES | 2014 |
|
RU2553515C1 |
METHOD OF USE IN THERAPY | 2010 |
|
RU2579659C2 |
ANTIBODIES | 2005 |
|
RU2482131C2 |
ANTIBACTERIAL PEPTIDES | 2007 |
|
RU2468033C2 |
COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
THERAPEUTIC VACCINE | 2006 |
|
RU2440824C2 |
IMMUNOGEN PEPTIDE AGAINST GROUP A STREPTOCOCCI | 2018 |
|
RU2775621C2 |
IMMUNOPROPHYLACTIC CANCER VACCINE | 2004 |
|
RU2556128C2 |
MESOTHELINE-TARGETED CANCER VACCINES AND THEIR APPLICATION | 2018 |
|
RU2751252C1 |
Authors
Dates
2016-01-20—Published
2010-11-26—Filed